Lund-Hansen Torben
- SEC CIK
- 0001753134
No open-market purchases or sales filed in the past year.
Current role at each company
- YMAB Y-mAbs Therapeutics, Inc.SVP & CHIEF TECHNICAL OFFICERas of Aug 30, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Lund-Hansen Torben as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 30, 2024 (view filing) | Aug 28 | 2 days | Lund-Hansen TorbenSVP & CHIEF TECHNICAL OFFICER | SSale | −50.0K | $15.37 | −$768.5K | −58.4%35.6K after |